148 related articles for article (PubMed ID: 3906612)
1. Toxic epidermal necrolysis (TEN) can be considered an extreme and serious form of erythema multiforme.
Oranje A; De Groot R
Pediatr Dermatol; 1985 Nov; 3(1):83. PubMed ID: 3906612
[No Abstract] [Full Text] [Related]
2. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
3. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis.
Williams PM; Conklin RJ
Dent Clin North Am; 2005 Jan; 49(1):67-76, viii. PubMed ID: 15567361
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis associated with Klebsiella pneumoniae sepsis.
Picard E; Gillis D; Klapholz L; Schreiber L; Engelhard D
Pediatr Dermatol; 1994 Dec; 11(4):331-4. PubMed ID: 7899184
[TBL] [Abstract][Full Text] [Related]
5. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
Niemeijer IC; van Praag MC; van Gemund N
Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
[TBL] [Abstract][Full Text] [Related]
6. Head and neck manifestations of erythema multiforme in children.
Stewart MG; Duncan NO; Franklin DJ; Friedman EM; Sulek M
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):236-42. PubMed ID: 8084631
[TBL] [Abstract][Full Text] [Related]
7. Toxic epidermal necrolysis in a 6-week-old infant.
Hawk RJ; Storer JS; Daum RS
Pediatr Dermatol; 1985 Mar; 2(3):197-200. PubMed ID: 3887341
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
[TBL] [Abstract][Full Text] [Related]
9. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
[TBL] [Abstract][Full Text] [Related]
10. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
Hosaka H; Ohtoshi S; Nakada T; Iijima M
J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
[TBL] [Abstract][Full Text] [Related]
11. Erythema multiforme and toxic epidermal necrolysis: a comparative study.
Paquet P; Piérard GE
Am J Dermatopathol; 1997 Apr; 19(2):127-32. PubMed ID: 9129696
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Fabbri P
Br J Dermatol; 2008 May; 158(5):1163-6. PubMed ID: 18363765
[No Abstract] [Full Text] [Related]
13. [Aspects of the interrelationship of erythema multiforme exudativum and of the Stevens-Johnson and Lyell syndromes].
Bukharovich MN
Vestn Dermatol Venerol; 1980 Sep; (9):33-4. PubMed ID: 7424151
[No Abstract] [Full Text] [Related]
14. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
15. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
16. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Wilkins J; Morrison L; White CR
Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
[TBL] [Abstract][Full Text] [Related]
18. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
[TBL] [Abstract][Full Text] [Related]
19. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
20. Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine.
Arias D; Requena L; Hasson A; Gutierrez M; Domine M; Martin L; Barat A
J Cutan Pathol; 1991 Oct; 18(5):344-6. PubMed ID: 1761786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
